BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NYSE MKT: TXMD) announced today that it will present at the Stifel Nicolaus 2013 Healthcare Conference to be held September 11-12, 2013 at the Four Seasons Hotel Boston.
Robert Finizio, Co-Founder and Chief Executive Officer, will present on Thursday, September 12, 2013 at 3:50 p.m. EDT.
The presentation will also be available via a live audio webcast at the following link: http://www.veracast.com/webcasts/stifel/healthcare2013/61213535118.cfm
Following the presentation, a replay will be available through TherapeuticsMD’s website at www.therapeuticsmd.com under the "Investor Relations" section and will remain available for 30 days after the actual presentation date.
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. We manufacture and distribute branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD® and BocaGreenMD™ brands. We are currently developing advanced hormone therapy pharmaceutical products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. We are also evaluating various other potential indications for our hormone technology, including oral contraception, preterm birth, vulvar and vaginal atrophy, and premature ovarian failure. More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmd.com, www.vitamedmdrx.com, and www.bocagreenmd.com.
vitaMedMD® is a registered trademark and TherapeuticsMD® and BocaGreenMD™ are trademarks of TherapeuticsMD, Inc.